ABIDE - Trademark Details
Status: 734 - Fifth Extension - Granted
Image for trademark with serial number 88193779
Serial Number
88193779
Word Mark
ABIDE
Status
734 - Fifth Extension - Granted
Status Date
2021-12-03
Filing Date
2018-11-14
Mark Drawing
4000 - Standard character mark Typeset
Published for Opposition Date
2019-04-30
Attorney Name
Alexander Reid
Law Office Assigned Location Code
O30
Employee Name
SHANOSKI, JOANNA MARIE
Statements
Goods and Services
Medical and pharmaceutical research services; pharmaceutical research and development; research and development in pharmacology for the purpose of treating diseases involving lipid signaling pathways; research and development in pharmacology for the purpose of treating diseases involving the signaling pathways of the central nervous system; medical research for use in treating central nervous system disorders; pharmaceutical research for treating acromegaly, neuroendocrine tumors, Cushing's Disease, hyperinsulinism, and chronic pain; medical research for the treatment or prevention of dermatological, cardiovascular, hematological, bone, respiratory, central nervous system, endocrinological, circulatory, gastroenterological, digestive, hormonal, diabetic, muscular, rheumatic, immune system, ocular and metabolic diseases and disorders; providing medical and scientific research information in the field of pharmaceuticals; medical and scientific research, namely, conducting clinical trials for others; laboratory research services relating to pharmaceuticals; pharmaceutical research in the field of enzymes that employ hyper-nucleophilic active-site residues for catalysis, namely, serine, threonine and cysteine hydrolases, proteases, and acyl transferases; pharmaceutical research in the fields of immunology, namely, rheumatology, oncology, namely, immuno-oncology, pulmonology, gastroenterology, endocrinology, dermatology, urology, gynecology, namely, fertility, infectiology, namely, virology, ophthalmology, hepatology, neurology, geriatrics, laboratory medicine, clinical diagnostics, genetics and phenomics, pathology and forensics, proteomics, veterinary medicine and diagnostics, and pharmaceutical research tool development; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; pharmaceutical research using enzymes that employ hyper-nucleophilic active-site residues for catalysis, namely, serine, threonine and cysteine hydrolases, proteases, and acyl transferases for use in drug development; pharmaceutical research, namely, research relating to enzymes that employ hyper-nucleophilic active-site residues for catalysis, namely, serine, threonine and cysteine hydrolases, proteases, and acyl transferases for improving pharmacological properties; pharmaceutical research, namely, research relating to enzymes that employ hyper-nucleophilic active-site residues for catalysis, namely, serine, threonine and cysteine hydrolases, proteases, and acyl transferases for use in connection with a wide variety of therapeutic areas
Classification Information
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2018-12-11
Primary Code
042
Current Trademark Owners
Party Name
H. LUNDBECK A/S
Party Type
22 - 2nd New Owner After Publication
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Name
H. LUNDBECK A/S
Party Type
22 - 2nd New Owner After Publication
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Party Name
LUNDBECK LA JOLLA RESEARCH CENTER, INC.
Party Type
21 - 1st New Owner After Publication
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Party Name
Abide Therapeutics, Inc.
Party Type
20 - Owner at Publication
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Party Name
Abide Therapeutics, Inc.
Party Type
10 - Original Applicant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Alexander Reid
Address
Please log in with your Justia account to see this address.
Trademark Events
Event DateEvent Description
2018-11-17NEW APPLICATION ENTERED IN TRAM
2018-12-11NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
2019-02-19ASSIGNED TO EXAMINER
2019-02-27EXAMINERS AMENDMENT -WRITTEN
2019-02-27EXAMINERS AMENDMENT E-MAILED
2019-02-27NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
2019-02-27EXAMINER'S AMENDMENT ENTERED
2019-02-27APPROVED FOR PUB - PRINCIPAL REGISTER
2019-03-22ASSIGNED TO LIE
2019-03-22LAW OFFICE PUBLICATION REVIEW COMPLETED
2019-04-10NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
2019-04-30PUBLISHED FOR OPPOSITION
2019-04-30OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
2019-06-25NOA E-MAILED - SOU REQUIRED FROM APPLICANT
2019-10-09AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
2019-12-17TEAS EXTENSION RECEIVED
2019-12-17EXTENSION 1 FILED
2019-12-17EXTENSION 1 GRANTED
2019-12-19NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2020-04-29AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
2020-06-08TEAS CHANGE OF OWNER ADDRESS RECEIVED
2020-06-08TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
2020-06-08ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
2020-06-08TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
2020-06-08TEAS CHANGE OF CORRESPONDENCE RECEIVED
2020-06-08APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
2020-06-09TEAS EXTENSION RECEIVED
2020-06-09EXTENSION 2 FILED
2020-06-09EXTENSION 2 GRANTED
2020-06-11NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2020-12-04TEAS EXTENSION RECEIVED
2020-12-04EXTENSION 3 FILED
2020-12-04EXTENSION 3 GRANTED
2020-12-08NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2021-05-26TEAS EXTENSION RECEIVED
2021-05-26EXTENSION 4 FILED
2021-05-26EXTENSION 4 GRANTED
2021-05-28NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2021-11-16TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
2021-11-16ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
2021-11-16TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
2021-11-16TEAS CHANGE OF CORRESPONDENCE RECEIVED
2021-11-23TEAS EXTENSION RECEIVED
2021-12-03CASE ASSIGNED TO INTENT TO USE PARALEGAL
2021-11-23EXTENSION 5 FILED
2021-12-03EXTENSION 5 GRANTED
2021-12-04NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED